Transcriptomic profiling as proof of concept for investigation of collecting duct carcinoma (CDC).
In the second part of a 2-part series, Rana R. McKay, MD, associate professor of Medicine and Urology, Moores Cancer Center, University of California San Diego, discusses second-line treatment options ...
The different types of RCC are generally distinguished by the way that cancer cells appear when viewed under a microscope. Keep reading to learn about the three most common subtypes, which account for ...
* not calculated for limited sample size. This is an ASCO Meeting Abstract from the 2022 ASCO Genitourinary Cancers Symposium. This abstract does not include a full text component.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results